>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
血清和组织PLAC1在结肠癌诊断和判断淋巴结转移风险中的临床价值
作者:闫龙超  杨琳  杨明  潘吉勇 
单位:大连市第三人民医院 普通外科一病房, 辽宁 大连 116000
关键词:胎盘特异性基因1 结肠癌 淋巴结转移 临床预测 临床特征 
分类号:R735.35
出版年·卷·期(页码):2022·41·第一期(102-108)
摘要:

目的:研究血清和组织胎盘特异性基因1(PLAC1)在结肠癌诊断和判断淋巴结转移风险中的临床价值。方法:于2021年3月从TCGA数据库下载RNA-Seq表达数据和患者临床特征资料进行生物信息学分析。另外选取2018年3月至2021年3月在我院完成结肠癌根治术的151例结肠癌患者作为研究对象(结肠癌组),另外选取150例非癌患者的血清样本作为正常组,通过免疫组化法和酶联免疫吸附测定法检测PLAC1在组织和血清中的表达情况。结果:通过生物信息学分析,肿瘤组织中PLAC1的表达量明显高于正常组织(P<0.01),且高表达的PLAC1与远处转移、淋巴结转移、临床分期、总生存预后和无病生存预后有关(P<0.05)。与癌旁正常组织相比,肿瘤组织中PLAC1蛋白阳性表达率显著升高[64.90%(98/151)vs.18.54%(28/151),P<0.05]。正常组和结肠癌组血清PLAC1水平分别为42.51(22.90,62.85) ng·ml-1和86.70(45.50,210.00) ng·ml-1,结肠癌组患者血清PLAC1水平明显高于正常组(P<0.05)。此外,组织PLAC1高表达与肿瘤直径>5 cm、淋巴结转移和TNM Ⅲ~Ⅳ分期有关(P<0.05);而血清PLAC1水平亦与淋巴结转移和TNM Ⅲ~Ⅳ分期有关(P<0.05)。经受试者工作特征(ROC)曲线分析,血清PLAC1水平诊断结肠癌的曲线下面积(AUC)为0.962(95%CI:0.934~0.989),预测结肠癌淋巴结转移的AUC为0.868(95%CI:0.828~0.908)。结论:结肠癌组织和血清PLAC1水平普遍升高,这与淋巴结转移和疾病进展有关;检测血清PLAC1水平对于结肠癌诊断和预测淋巴结转移风险能提供一定的可参考信息。

Objective: To investigate the clinical value of serum or tissue placenta-specific 1(PLAC1) in the diagnosis of colon cancer and the judgment of lymph node metastasis risk. Methods: Bioinformatics analysis by downloading RNA-Seq expression data and patient clinical characteristics from the TCGA database in march 2021. From March 2018 to March 2021, 151 patients underwent resection of colon cancer and pathologically diagnosed colorectal cancer in our hospital were selected as the colon cancer group. Another 150 cases without any cancer were also selected into this study as the normal group. The expression of PLAC1 in colon cancer tissues or serum samples was analyzed by immunohistochemistry or ELISA. Results: The expression of PLAC1 in tumor tissue was significantly higher than that in normal tissue by bioinformatics analysis(P<0.01), and the high expression of PLAC1 was associated with distant metastasis, lymph node metastasis, clinical stage, total survival and disease-free survival(P<0.05). The positive expression rate of PLAC1 protein in tumor tissues was significantly higher than that in the para-cancerous normal tissues[64.90%(98/151) vs. 18.54%(28/151), P<0.05]. The serum PLAC1 level in the normal group and colon cancer group were 42.51(22.90,62.85) ng·ml-1 and 86.70(45.50,210.00) ng·ml-1,respectively. And the serum PLAC1 level in the colon cancer group was significantly higher than that in the normal group(P<0.05). In addition, high expression of PLAC1 of tissues was associated with tumor diameter >5 cm, lymph node metastasis and TNM Ⅲ~Ⅳ stage(P<0.05), and the serum PLAC1 level was associated with lymph node metastasis and TNM Ⅲ-Ⅳ stage(P<0.05). By ROC curve, the AUC of serum PLAC1 level for the diagnosis of colon cancer was 0.962(95%CI:0.934-0.989) and the AUC for the prediction of lymph node metastasis was 0.868(95%CI:0.828-0.908). Conclusion: The levels of PLAC1 in colon cancer tissues and serum are generally elevated, which are related to lymph node metastasis and disease progression. The detection of serum PLAC1 level can provide certain reference information for the diagnosis of colon cancer and prediction of lymph node metastasis risk.

参考文献:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68(6):394-424.
[2] 高博, 陈卓妙语, 王秋生, 等.基于权重基因共表达分析的结肠癌肝转移相关基因挖掘与验证[J].中华结直肠疾病电子杂志, 2020, 8(4):363-369.
[3] YUAN H Y, WANG X Y, SHI C M, et al.Plac1 is a key regulator of the inflammatory response and immune tolerance in mammary tumorigenesis[J].Sci Rep, 2018, 8(1):5717.
[4] MAHMOUDIAN J, GHODS R, NAZARI M, et al.Expression profiling of plac1 in murine cancer cell lines[J].Exp Oncol, 2019, 41(1):7-13.
[5] 赵瑞, 李世拥, 安萍, 等.PLAC1在结直肠癌及其肝转移组织中的表达及临床意义[J].中华普外科手术学杂志(电子版), 2012, 6(3):281-285.
[6] 杜飞, 董亚萍, 朴成钢, 等.结肠癌靶向治疗的研究进展[J].生命的化学, 2018, 17(2):259-266.
[7] 邹小农, 贾漫漫, 王鑫, 等.《2020全球癌症报告》要点解读[J].中国胸心血管外科临床杂志, 2021, 28(1):11-18.
[8] 刘芳芳.结直肠癌免疫治疗的研究及前景展望[J].世界华人消化杂志, 2015, 28:4464-4472.
[9] MAHMOUDIAN J, GHODS R, NAZARI M, et al.PLAC1:biology and potential application in cancer immunotherapy[J].Cancer Immunol Immunother, 2019, 68(7):1039-1058.
[10] 李永飞.癌-睾丸抗原-PLAC1在乳腺癌侵袭转移中的作用及机制探讨[D].南京:南京医科大学, 2018.
[11] SILVA W A, GHJATIC S, RITTER E, et al.PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses[J].Cancer Immun, 2007, 7(11):18.
[12] YUAN H, CHEN V, BOISVERT M, et al.PLAC1 as a serum biomarker for breast cancer[J].PLoS One, 2018, 13(2):e0192106.
[13] LI Y, CHU J, LI J, et al.Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway[J].Mol Oncol, 2018, 12(8):1233-1248.
[14] REN Y, LV Y X, LI T Y, et al.High expression of PLAC1 in colon cancer as a predictor of poor prognosis:a study based on TCGA data[J].Gene, 2020, 763(12):145072.
[15] JIAO T W, LI Y, GAO T, et al.MTA3 regulates malignant progression of colorectal cancer through Wnt signaling pathway[J].Tumour Biol, 2017, 39(3):1010428317695027.
[16] LAPORTE G A, LEGUISAMO N M, KALIL A N, et al.Clinical importance of DNA repair in sporadic colorectal cancer[J].Crit Rev Oncol Hematol, 2018, 126(7):168-185.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 343109 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364